# The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps

> **NCT05131464** · PHASE2 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 46 (actual)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **DRUG:** CM310

## Key facts

- **NCT ID:** NCT05131464
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-30
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05131464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05131464, "The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05131464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*